The Oklahoma Proton Center celebrated the graduation of its 4,000th patient. Mr. Eric Green was a 59-year-old prostate cancer patient who chose the Oklahoma...
HanAll Biopharma and Daewoong Pharmaceutical announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on...
Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, announced an expanded partnership with DaVita Inc.,...
Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
